NextGenVis fellow’s spin-off Reperio raises its first investment

posted in: Other news | 0

Reperio, an UMCG spin-off company founded by NextGenVis fellow Alessandro Grillini, raised its first major investment. The company aims to accelerate the diagnostic process for glaucoma and neurodegenerative diseases using eye-tracking technology and analyses developed by Alessandro and colleagues during his tenure at our Visual Neuroscience lab.

Alessandro Grillini still during his PhD and while briefly not working on his advanced analyses.

More details can be found in the press release of Reperio.